Xeris Biopharma Holdings Inc
(FRA:2B30)
€
7.11
+0.020 (+0.28%)
Market Cap: 1.27 Bil
Enterprise Value: 1.40 Bil
PE Ratio: 139.67
PB Ratio: 111.73
GF Score: 74/100 Xeris Biopharma Holdings Inc (FRA:2B30) Transcripts
- 1